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Background/aim: The aim of this study was to compare renal and pancreatic apparent diffusion-coefficient (ADC) values of diabetic
patients and control subjects and to examine their potential association with several diabetes-related clinical parameters.
Materials and methods: A total of 80 sex- and age-matched patients were included in the study. Of them, 40 were patients with type
2 diabetes and 40 were nondiabetic participants. Abdominal diffusion-weighted MRIs of both groups were retrospectively reviewed.
Diabetes-related clinical parameters were recorded.
Results: The difference between the mean ADC values of the patient group and the control group was significant (p = 0.012). It was also
found that the mean pancreatic ADC values of diabetic patients and the control group significantly differed (p = 0.02). Besides, there
were positive correlations between the mean pancreatic ADC values and age, Hb1Ac level, treatment type, and disease duration (p <
0.05). While eGFR values positively correlated with the mean renal ADC values (p < 0.05), there were negative correlations between
such values and age, serum creatinine level, and disease duration (p < 0.05).
Conclusion: Renal and pancreatic ADC values of diabetic patients could potentially play a role, as markers of renal and pancreatic
functions, in clinical decisions in the follow-up of such patients.
Key words: Diabetes mellitus, pancreas, kidney, magnetic resonance imaging, diffusion-weighted imaging

1. Introduction
Diabetes mellitus is considered a multisystemic disease,
leading to multiple organ and system damages [1,2].
Ending with terminal kidney failure, diabetic nephropathy
is among the most prevalent complications of type 2
diabetes. It is shown with glomerulosclerosis, papillary
necrosis, chronic interstitial nephritis, arteriolar
nephrosclerosis, various tubular lesions, and fibrosis [3,4].
In type 2 diabetes mellitus, deposits replaced within the
pancreatic islet occur in patients with hyperglycemia [5,6].
It has been suggested that these islet amyloid polypeptide
deposits have a considerable impact on the pathogenesis
of glucose intolerance, which may be associated with
progressive cell mass loss and pancreatic fibrosis [5,7].
Diffusion-weighted imaging (DWI) is a kind of
magnetic resonance imaging (MRI) technique. It is also a
technique developed based on the movements of randomly
selected water molecules within the tissue; therefore, it

can be used to examine tissues’ structural properties.
DWI results in apparent diffusion coefficient (ADC)
values, which offer considerable data about the textures
examined. The ADC value, which is calculated from DWI,
is a quantitative parameter. It is possible to calculate ADC
values for diverse tissues by drawing a region of interest
(ROI) on the map [8,9]. DWI can measure the amount
of diffusion in the pancreas and kidneys and assess the
damage by chronic inflammation and fibrosis [3–5,10–12].
To the best of our knowledge, the literature reserves only
a few studies investigating the use of DWI for the damage
to the kidneys in diabetic patients [3,4,11–14]. However,
there is no study evaluating damages to both pancreas and
the kidneys in such patients.
Ultimately, the present study compared renal and
pancreatic ADC values of type 2 diabetes and nondiabetic
control subjects and investigated their potential association
with several diabetes-related clinical parameters.
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2. Materials and methods
2.1. Study population and inclusion criteria
Abdominal diffusion-weighted MRIs of the patients,
which had been recorded in a computer automation
system from January 2015 to April 2018 in our clinic, were
retrospectively reviewed. Accordingly, the study recruited
a total of 80 sex- and age-matched patients; of them, 40
patients with type 2 diabetes and 40 nondiabetic control
subjects satisfied the inclusion criteria of our work. The
diagnosis of type 2 diabetes was considered according to
the American Diabetes Association criteria [15]. Both
groups’ abdominal diffusion-weighted MRI, taken for the
examinations to diagnose liver and adrenal pathologies,
were reviewed. Beforehand, estimated glomerular filtration
rate (eGFR) values, glycated hemoglobin (HbA1c) levels,
serum creatinine levels, and treatment types and disease
durations within the last 1 month were retrieved from
the records of type 2 diabetes patients in the endocrine
polyclinic.
The primary inclusion criterion for diabetic patients
was to be an adult patient with type 2 diabetes and with
follow-up in our endocrine polyclinic, while the criterion
for the control group was to be an adult patient without
diabetes mellitus, hypertension, or heart and/or kidney
diseases.
This study was carried out with regard to the Helsinki
Declaration. In this context, the hospital ethics committee
approved this study and granted permission to gather
patients’ data for relevant examinations (Kırıkkale
University Clinical Research Ethics Committee, Decision
Number: 13/03, Date: May 29, 2018).
2.2. Exclusion criteria
The exclusion criteria for all groups were to be with
pancreatic and kidney masses, to be with or to have a
history of pancreatitis, to be with renal insufficiency,
to have single kidney or kidney anomaly, urinary tract
infections, or some other diseases, to be with liver and
malignant adrenal masses affecting the kidney and
pancreas anatomically and functionally, to be under the
age of 18 and over 65, and to be with incomplete diffusion
MRI images and data.
2.3. Diffusion-weighted imaging examination
A1.5-Tesla MRI device (Philips MRI Systems, Achieva
Release 3.2 Level 2013-10-21; Philips Medical Systems
Nederland B.V.), using a 16-channel body torso array coil,
was used to perform MRIs. DWI was done by applying
diffusion-sensitive gradients with 2 different β values (β
= 0 and β = 800 mm2/s) to the single-shot echo-planar
sequence every 3 directions (x, y, z) in the axial plane.
DWI included the following sequences: echo time (TE)/
repetition time (TR) of 2335/66 ms, spectral presaturation
with inversion recovery (SPIR) fat-suppressed, the field of
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view of 380 mm, matrix size of 128 × 128 mm, number
of excitations of 2, slice thickness of 4 mm, and slice
number of 15, the scan time of 28 s, slice gap of 1.2 mm,
and diffusion sensitivity of 0 or 800 s/mm2. Then, the ADC
maps were reconstructed through these images. Magnitude
images were extracted from the MRI system to a separate
workstation to calculate values and trace images.
A single radiologist blind to clinical information
(A.Ö.) examined all images on a workstation. Three ROI
were drawn on the head, body, and tail of the pancreas
(ovoid circles area, 30–50 mm2, Figure 1), and mean ADC
values were calculated for these parts of the pancreas.
After each kidney was divided into three regions (upper,
mid, and lower thirds), three ROIs were drawn on each
of these regions (ovoid circles area, 25–40 mm2, Figure 2).
The mean ADC values were calculated for each region of
the kidneys. Overall, the mean renal and pancreatic ADC
values were used for statistical comparisons.
2.4. Statistical analysis
We used SPSS 20.0 (IBM Corp., Armonk, NY, USA) for the
statistical analyses. Continuous variables were described
as mean and standard deviation (SD). The independent
t-test was used to detect between-group differences.
Chi-square was used to compare categorical variables,
such as sex, between the groups. While the Pearson
product-moment correlation coefficient was calculated
to reveal the relationship between numeric variables, the
Spearman’s correlation rho efficient test was utilized to see

Figure 1. The pancreas ADC measurements of a 56-year-old
female type 2 diabetes patient.
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the relationship between categorical variables. A p-value
of 0.05 was accepted as statistically significant in all
statistical analyses.
The best cut-off values for renal and pancreatic mean
ADC values were identified using receiver-operating
characteristic (ROC) curve analysis on the MedCalc
program (version 19.5.3). Subsequently, the positive
predictive value (PPV), specificity, sensitivity, and
negative predictive value (NPV) were obtained. The area
under the curve (AUC) was used to determine how ADC
values could distinguish between the patient and control
groups.
A power analysis was performed using a 20%
difference between the mean ADC values of both kidneys
at an α level of 0.05 and a β level of 0.08; therefore, the
minimum sample size was calculated as 78 patients. A
total of 80 patients, 40 patients with type 2 diabetes, were
included in the study, considering the similar comparative
studies in the relevant literature [3,4,16–18].

Figure 2. The renal ADC measurements of a 56-year-old female
type 2 diabetes patient.

3. Results
While there were 14 males and 26 females in the patient
group with the mean age of 51.7 ± 9 years (range, 20–65
years), the control group was composed of 18 males
and 22 females with the mean age of 51.1 ± 11 years
(range, 21–65 years). The groups were congruent with
each other in terms of age and sex (p > 0.05). Age, sex,
HbA1c, and serum creatinine levels, treatment types, and
disease durations in both groups are shown in Table 1
(treatment codes: code 1, only oral antidiabetic; code 2,
oral antidiabetic + insulin; and code 3, only insulin).

Table 1. Clinical and demographic features of the groups.
Type 2 diabetes patients
(n = 40)

Control group
(n = 40)

p values

Sex, M/F

14/26

18/22

0.494a

Age, years

51.7 ± 9 (20–65)

51.1 ± 11 (21–65)

0.781b

Hb1Ac, %

8 ± 2.2 (5.2–16)

eGFR, mL/min

90.4 ± 24.7 (13.9–159.6)

Creatinine, mg/dL

0.96 ± 0.64 (0.5–4.5)

Treatment, code 1/2/3

23/6/11

Duration of disease, years

9 ± 5.3 (0.5–20)

Values indicate the mean ± standard deviation and range. Treatment codes, code 1: only oral antidiabetic;
code 2: oral antidiabetic + insulin; code 3: only insulin; M: male, F: female. HbA1c: glycated hemoglobin,
eGFR: estimated glomerular filtration rate.
a
p-value shows the results of chi square analysis.
b
p-value shows the results of the independent t-test.
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Table 2. Comparison of mean ADC values of renal and pancreas between type 2 diabetes patients and
control group.
Type 2 diabetes patients
(n = 40)

Control group
(n = 40)

p values

Right kidney mean ADC

1932 ± 166

2008 ± 104

0.017

Left kidney mean ADC

2022 ± 159

2107 ± 152

0.017

Both kidneys’ mean ADC

1977 ± 157

2057 ± 120

0.012

Pancreas mean ADC

1390 ± 139

1307 ± 87

0.002

Values indicate the mean ± standard deviation (×10–6 mm2/s).
ADC, apparent diffusion coefficient.
p-value shows the results of the independent t-test.

The mean renal ADC values were found to be 1977 ±
157 10–6 mm2/s in diabetic patients. In the control group,
it was 2057 ± 120 10–6 mm2/s. The differences between
the mean ADC values of the right/left kidney and both
kidneys in the control group and the patient group were
statistically significant (p = 0.012, p = 0.017, and p = 0.017,
respectively) (Table 2). The mean pancreatic ADC values
of the control group (1307 ± 87 10–6 mm2/s) and patient
group (1390 ± 139 10–6 mm2/s) also significantly differed
(p = 0.02) (Table 2).
Meanwhile, age, Hb1Ac level, treatment type, and
disease duration were significantly and positively
correlated with the mean pancreatic ADC values (p <
0.05). There were also positive correlations between eGFR
values and the mean ADC values of the kidneys (p < 0.05)
(Table 3). Nevertheless, there were negative correlations
between age, serum creatinine level, and disease duration
and the mean renal ADC values (p < 0.05) (Table 3).
The ROC curve analysis revealed that the area under
the curve was 0.674 (95% CI = 0.560–0.775) for the mean
ADC values for both kidneys and 0.709 (95% CI = 0.597–
0.806) for the mean pancreatic ADC values. The cut-off
point less than 1957 10–6 mm2/s for the mean renal ADC
values had a sensitivity of 52.5%, a specificity of 80%, a
PPV of 72.41%, and an NPV of 62.74%. However, the
cut-off point greater than 1345 10–6 mm2/s for the mean
pancreas ADC values had a sensitivity of 70%, a specificity
of 72.5%, a PPV of 71.79%, and an NPV of 70.73% (Figures
3A and 3B).

Table 3. Correlation test results in type 2 diabetes patients.

4. Discussion
We found lower renal ADC values in patients with type 2
diabetes than the control group, and there was a significant
correlation between renal ADC and eGFR values. Cakmak
et al. [3] reported that renal ADC values were significantly
correlated with the clinical stages of diabetic nephropathy.
They also determined a significant positive correlation

ADC, apparent diffusion coefficient. Code 1: male, Code 2:
female. y. HbA1c: glycated hemoglobin, eGFR: estimated
glomerular filtration rate. Treatment codes, code 1: only oral
antidiabetic; code 2: oral antidiabetic + insulin; code 3: only
insulin.
a
p-value shows the results of Pearson’s correlation test.
b
p-value shows the results of Spearman’s correlation rho efficient
test.
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Mean ADC values
Both kidneys’

Mean ADC
values

Both kidneys’
Pancreas

Sex
Age, years
Hb1Ac, %
eGFR, mL/min
Creatinine, mg/dL
Treatment, code 1/2/3

r

–0.002

pa

0.99

r

–0.002

p

0.99

r

0.109

–0.263

p

0.503

0.101

r

–0.394

0.368

p

0.012

0.02

r

0.170

0.397

p

0.294

0.011

r

0.448

0.071

pa

0.004

0.663

r

–0.324

–0.137

p

0.041

0.4

r

0.109

0.446

p

0.501

0.004

r

–0.344

0.527

0.03

0.000

a

b

a

a

a

b

Duration of disease, years

Pancreas

p

a
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Figure 3. The receiver operating characteristic curves of ADC values (×10–6 mm2/s) differentiate type 2
diabetic patients from the control group. A. For the pancreas. B. For both kidneys. The blue curve represents
the receiver operating characteristic curve, and the red line represents the diagonal line used as a reference.

between the mean renal ADC values and eGFR values in
diabetic patients. Mrđanin et al. [4] reported that patients
with diabetic nephropathy had low renal ADC values and
that these values were significantly correlated with eGFR
values. Inoue et al. [12] also showed that ADC values of the
diabetic (n = 43) and nondiabetic (n = 76) patients suffering
from chronic kidney disease were significantly correlated
with eGFR values. Using diffusion tensor MRI, Lu et al.
[14] discovered that the diabetic subjects had significantly
lower medullary fractional anisotropy, ADC, and cortical
ADC values with an eGFR < 60 compared to the control
subjects. In the study of Xu et al. [19], renal ADC values
were observed to be significantly lower than expected at
most stages of chronic kidney disease, except stage 1, and
these values were found to be negatively correlated with
serum creatinine levels of the patients. Similarly, several
studies in the literature previously uncovered a decrease in
renal ADC values due to various acute and chronic kidney
diseases and a significant correlation of eGFR values
with ADC values [10–14,19,20]. This situation is likely
associated with interstitial fibrosis, glomerulosclerosis,
and tubular damage, as shown in the previous studies
[3,11]. In addition, the present study concluded a negative
correlation between the mean renal ADC values and age,
serum creatinine levels, and disease durations (Table 3).
We found a significant increase in the mean
pancreatic ADC values in patients with type 2 diabetes.
Such an increase in diffusion was suggested to be due to
hyperglycemia in the patients and chronic inflammation
and fibrosis occurring in the pancreas [5,21]. Noda et al.
[22] found that in type 2 diabetes, marked acinar atrophy
and pancreatic fibrosis significantly reduced islet mass
and pancreatic extracellular volume was significantly

higher. High extracellular volume explains the increased
diffusion. Furthermore, there were significant correlations
between the mean pancreatic ADC values and age, HbA1c
level, disease duration, and treatment type. In general,
studies on pancreatic DWI in diabetic patients are limited
in the literature. Noda et al. [5] concluded that there was a
potential marker between high HbA1c level and pancreatic
fibrosis, which was fostered by our findings. In addition,
the present study reached a correlation between patients
on insulin therapy and pancreatic ADC values, which
indicates an increased need for insulin due to pancreatic
fibrosis.
The ROC curve analysis was also able to determine
the cut-off value of the mean ADC of both kidneys (1957
10–6 mm2/s) with 52.5% sensitivity and 80% specificity, and
the cut-off value of the mean pancreatic ADC (1345 10–6
mm2/s) with 70% sensitivity and 72.5% specificity. Except
for the sensitivities of the renal values, sensitivities and
specificities of all ADC cut-off values were calculated to
be high.
There were, on the other hand, some limitations to
this study. Firstly, only one reader did the ROI placement
and reading, and interobserver variability could not be
assessed. Secondly, ROI measurements were limited
only to the renal cortex; this study did not evaluate
renal medullary changes. Although multiple ROIs were
placed in the cortical regions, a slight interference may
have been likely with medullary areas, which is thought
to have affected the results. Thirdly, no comparison was
made between the nephropathy stage and ADC values.
Finally, histopathologic differences were not considered
in the correlation analyses. Still, the present study is
strongly believed to have significant contributions to the
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literature. Further studies are recommended to consider
and overcome the limitations mentioned above.
In conclusion, in this study, low renal ADC values in
patients with type 2 diabetes were found to be significantly
correlated with eGFR, serum creatinine level, age, and
disease duration. Moreover, high pancreatic ADC values
were revealed to be congruent with age, Hb1Ac level,
disease duration, and treatment type. Renal and pancreatic
ADC values of diabetic patients could potentially play a
role, as markers of renal and pancreatic functions, in
making clinical decisions in the follow-up of such patients.
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